Obatoclax

Overview

Obatoclax (GX15-070), a BH3 mimetic, is a pan- BCL-2 family proteins inhibitor with a K i of 220 nM for BCL-2 . Obatoclax induces autophagy -dependent cell death and targets cyclin D1 for proteasomal degradation. Obatoclax has anti-cancer and broad-spectrum antiparasitic activity.

Application

Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Infection | Products > Signaling Pathways > Bcl-2 Family | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Parasite

Product Information

• Catalog No.: HY-10969A
• CAS No.: 803712-67-6
• Molecular Formula: C20H19N3O
• Molecular Weight: 317.38
• Purity: 98.04%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (7.88 mM); Clear solution
• Availability: In-stock

Source

Original product source